Citation Impact
Citing Papers
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
ESUR prostate MR guidelines 2012
2012 Standout
Characterization of Calcium Release-activated Apoptosis of LNCaP Prostate Cancer Cells
2000
GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer
2004
Cancer burden in the year 2000. The global picture
2001 Standout
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
2003
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)
2000
Regulation of cell death: the calcium–apoptosis link
2003 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
2000 Standout
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Permutation tests for joinpoint regression with applications to cancer rates
2000 Standout
Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study
2000
Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial
2004
Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial
1999
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 Standout
Developmental estrogenization and prostatic neoplasia
1994
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
The Human p73 Promoter: Characterization and Identification of Functional E2F Binding Sites
2002 StandoutNobel
Prostatic intraepithelial neoplasia and prostate-specific antigen
1993
The development of androgen-independent prostate cancer
2001 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy
2003
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2015 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Autophagy in Human Health and Disease
2013 Standout
Trends in Reporting Gleason Score 1991 to 2001: Changes in the Pathologist's Practice
2004
Molecular genetics of prostate cancer
2000
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program
2002
The Role of New Modalities in the Early Detection and Diagnosis of Prostate Cancer
1989
Prostate cancer and the androgen receptor: Strategies for the development of novel therapeutics
2000
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
p63 and p73: old members of a new family
2000 StandoutNobel
Screening for prostate cancer without digital rectal examination and transrectal ultrasound: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
2005
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
2006 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Current strategies in the management of hormone refractory prostate cancer
2003
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Androgen receptors and their biology
2001
Role of the newer p53 family proteins in malignancy
2001 StandoutNobel
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma
1997
AR Possesses an Intrinsic Hormone-Independent Transcriptional Activity
2002
Observations on the early detection of prostate cancer from the American Cancer Society national prostate cancer detection project
1997
Prostatic Specific Antigen
1994
Global cancer statistics in the year 2000
2001 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Transition Zone Prostate Cancers: Features, Detection, Localization, and Staging at Endorectal MR Imaging
2006
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Male reproductive health and environmental xenoestrogens.
1996 Standout
Adenocarcinoma of the Vagina
1971 Standout
Transplacental Carcinogenesis by Stilbestrol
1971 Standout
Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.
1998
Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves
1994
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
Signal transduction by reactive oxygen species
2011 Standout
Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
1997
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient Outcome
2002
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
Mechanisms of Estrogen Action
2001 Standout
Diagnostic Methods in the Detection of Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men
1992
The diagnosis, management, treatment and costs of prostate cancer in England and Wales.
1997
ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMA
1972 StandoutNobel
The Role of Vitamin D in Cancer Prevention
2005 Standout
Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer
2005
Diagnosis of Primary Cancer of the Liver
1971
Adenocarcinoma of the vagina in adolescence.A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)
1970
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
2001
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
1995
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Angiographic Assessment of Gross Anatomy of Hepatocellular Carcinoma: Comparison of Celiac Angiograms and Liver Pathology in 100 Cases
1977
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663
2003
Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells.
1995
Molecular Genetics and Epidemiology of Prostate Carcinoma
1999
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
1999
Peroxiredoxin 1 Interacts with Androgen Receptor and Enhances Its Transactivation
2007
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.
2001
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Frequent alteration of p63 expression in human primary bladder carcinomas.
2000
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
The Androgen Axis in Recurrent Prostate Cancer
2004
Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
1995
Works of D B Siders being referenced
Transrectal biopsy of the prostate guided with transrectal US: longitudinal and multiplanar scanning.
1989
Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound
1992
Transrectal ultrasound in the diagnosis and staging of local disease after I125 seed implantation for prostate cancer
1988
Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer
1992
The Role of Transrectal Ultrasound In the Early Detection of Prostate Cancer
1989
Prostate cancer: Transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer
1991
Pathology review in an early prostate cancer detection program: Results from the american cancer society‐national prostate cancer detection project
1995
p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy
1998
Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma.
1989
Human Androgen ReceptorExpression in Prostate Cancerfollowing Androgen Ablation
1997
Transrectal ultrasound, digital rectal examination, and prostate-specific antigen: preliminary results of an early detection program for prostate cancer.
1991
p53 in Prostate Cancer: Frequent Expressed Transition Mutations
1994
Hormone ablation therapy as neoadjuvant treatment to radical prostatectomy.
1993
Gland cell prosoplasia (adenosis) of vagina
1965
The Spectrum of Angiographic Findings in Hepatoma
1970
Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.
1989